Options
Chemosensitizing activity of histone deacetylases inhibitory cyclic hydroxamic acids for combination chemotherapy of lymphatic leukemia
Fecha de emisión
2018
Autor(es)
Mishchenko D.V.
Neganova M.E.
Klimanova E.N.
Sashenkova T.E.
Klochkov S.G.
Shevtsova E.F.
Vystorop I.V.
Tarasov V.V.
Chubarev V.N.
Samsonova A.N.
Ashraf G.M.
Yarla N.S.
Aliev G.
DOI
10.2174/1568009617666170623104030
Temas
Chemosensitizing prop...
Combination chemother...
HDAC inhibitory activ...
Histone deacetylases
Hydroxamic acid
Lymphatic leukemia
cyclophosphamide
ferrozine
histone deacetylase i...
hydroxamic acid
trichostatin A
antineoplastic agent
histone deacetylase i...
hydroxamic acid
acute toxicity
animal experiment
antineoplastic activi...
Article
chemosensitivity
controlled study
drug structure
drug therapy
iron chelation
LD50
lipid peroxidation
lipophilicity
lymphatic leukemia
male
metastasis inhibition...
nonhuman
oxidative stress
rat
animal
chemistry
HeLa cell line
human
lymphatic leukemia
metabolism
mouse
pathology
Animals
Antineoplastic Combin...
HeLa Cells
Histone Deacetylase I...
Humans
Hydroxamic Acids
Leukemia, Lymphoid
Male
Mice
Rats
Archivo(s)